Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer

Nathan Bucay, Kirandeep Sekhon, Shahana Majid, Soichiro Yamamura, Varahram Shahryari, Z. Laura Tabatabai, Kirsten Greene, Yuichiro Tanaka, Rajvir Dahiya, Guoren Deng, Sharanjot Saini

Research output: Contribution to journalArticle

Abstract

Genomic loss of chromosome (chr) 8p21 region, containing prostate-specific NKX3.1 gene, is a frequent alteration of the prostate cancer (PCa) oncogenome. We propose a novel, paradigm shifting hypothesis that this frequently deleted locus is also associated with a cluster of microRNA genes- miR-3622a/b- that are lost in PCa and play an important mechanistic role in progression and metastasis. In this study, we demonstrate the role of miR-3622b in prostate cancer. Expression analyses in a cohort of PCa clinical specimens and cell lines show that miR-3622b expression is frequently lost in prostate cancer. Low miR-3622b expression was found to be associated with tumor progression and poor biochemical recurrence-free survival. Further, our analyses suggest that miR-3622b expression is a promising prostate cancer diagnostic biomarker that exhibits 100% specificity and 66% sensitivity. Restoration of miR-3622b expression in PCa cell lines led to reduced cellular viability, proliferation, invasiveness, migration and increased apoptosis. miR-3622b overexpression in vivo induced regression of established prostate tumor xenografts pointing to its therapeutic potential. Further, we found that miR-3622b directly represses Epidermal Growth Factor Receptor (EGFR). In conclusion, our study suggests that miR-3622b plays a tumor suppressive role and is frequently downregulated in prostate cancer, leading to EGFR upregulation. Importantly, miR-3622b has associated diagnostic, prognostic and therapeutic potential. Considering the association of chr8p21 loss with poor prognosis, our findings are highly significant and support a novel concept that associates a long standing observation of frequent loss of a chromosomal region with a novel miRNA in prostate cancer.

Original languageEnglish (US)
Pages (from-to)70388-70403
Number of pages16
JournalOncotarget
Volume7
Issue number43
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

MicroRNAs
Epidermal Growth Factor Receptor
Prostatic Neoplasms
Neoplasms
Prostate
Cell Line
Tumor Biomarkers
Multigene Family
Heterografts
Up-Regulation
Down-Regulation
Chromosomes
Cell Proliferation
Observation
Apoptosis
Neoplasm Metastasis
Recurrence
Sensitivity and Specificity
Therapeutics
Genes

Keywords

  • Chr8p21
  • EGFR
  • MiR-3622b
  • Prostate cancer
  • Tumor suppressor

ASJC Scopus subject areas

  • Oncology

Cite this

Bucay, N., Sekhon, K., Majid, S., Yamamura, S., Shahryari, V., Tabatabai, Z. L., ... Saini, S. (2016). Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer. Oncotarget, 7(43), 70388-70403. https://doi.org/10.18632/oncotarget.11865

Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer. / Bucay, Nathan; Sekhon, Kirandeep; Majid, Shahana; Yamamura, Soichiro; Shahryari, Varahram; Tabatabai, Z. Laura; Greene, Kirsten; Tanaka, Yuichiro; Dahiya, Rajvir; Deng, Guoren; Saini, Sharanjot.

In: Oncotarget, Vol. 7, No. 43, 01.01.2016, p. 70388-70403.

Research output: Contribution to journalArticle

Bucay, N, Sekhon, K, Majid, S, Yamamura, S, Shahryari, V, Tabatabai, ZL, Greene, K, Tanaka, Y, Dahiya, R, Deng, G & Saini, S 2016, 'Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer', Oncotarget, vol. 7, no. 43, pp. 70388-70403. https://doi.org/10.18632/oncotarget.11865
Bucay, Nathan ; Sekhon, Kirandeep ; Majid, Shahana ; Yamamura, Soichiro ; Shahryari, Varahram ; Tabatabai, Z. Laura ; Greene, Kirsten ; Tanaka, Yuichiro ; Dahiya, Rajvir ; Deng, Guoren ; Saini, Sharanjot. / Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer. In: Oncotarget. 2016 ; Vol. 7, No. 43. pp. 70388-70403.
@article{3fcffad598cd4c49b7be5e1f2461166d,
title = "Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer",
abstract = "Genomic loss of chromosome (chr) 8p21 region, containing prostate-specific NKX3.1 gene, is a frequent alteration of the prostate cancer (PCa) oncogenome. We propose a novel, paradigm shifting hypothesis that this frequently deleted locus is also associated with a cluster of microRNA genes- miR-3622a/b- that are lost in PCa and play an important mechanistic role in progression and metastasis. In this study, we demonstrate the role of miR-3622b in prostate cancer. Expression analyses in a cohort of PCa clinical specimens and cell lines show that miR-3622b expression is frequently lost in prostate cancer. Low miR-3622b expression was found to be associated with tumor progression and poor biochemical recurrence-free survival. Further, our analyses suggest that miR-3622b expression is a promising prostate cancer diagnostic biomarker that exhibits 100{\%} specificity and 66{\%} sensitivity. Restoration of miR-3622b expression in PCa cell lines led to reduced cellular viability, proliferation, invasiveness, migration and increased apoptosis. miR-3622b overexpression in vivo induced regression of established prostate tumor xenografts pointing to its therapeutic potential. Further, we found that miR-3622b directly represses Epidermal Growth Factor Receptor (EGFR). In conclusion, our study suggests that miR-3622b plays a tumor suppressive role and is frequently downregulated in prostate cancer, leading to EGFR upregulation. Importantly, miR-3622b has associated diagnostic, prognostic and therapeutic potential. Considering the association of chr8p21 loss with poor prognosis, our findings are highly significant and support a novel concept that associates a long standing observation of frequent loss of a chromosomal region with a novel miRNA in prostate cancer.",
keywords = "Chr8p21, EGFR, MiR-3622b, Prostate cancer, Tumor suppressor",
author = "Nathan Bucay and Kirandeep Sekhon and Shahana Majid and Soichiro Yamamura and Varahram Shahryari and Tabatabai, {Z. Laura} and Kirsten Greene and Yuichiro Tanaka and Rajvir Dahiya and Guoren Deng and Sharanjot Saini",
year = "2016",
month = "1",
day = "1",
doi = "10.18632/oncotarget.11865",
language = "English (US)",
volume = "7",
pages = "70388--70403",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "43",

}

TY - JOUR

T1 - Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer

AU - Bucay, Nathan

AU - Sekhon, Kirandeep

AU - Majid, Shahana

AU - Yamamura, Soichiro

AU - Shahryari, Varahram

AU - Tabatabai, Z. Laura

AU - Greene, Kirsten

AU - Tanaka, Yuichiro

AU - Dahiya, Rajvir

AU - Deng, Guoren

AU - Saini, Sharanjot

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Genomic loss of chromosome (chr) 8p21 region, containing prostate-specific NKX3.1 gene, is a frequent alteration of the prostate cancer (PCa) oncogenome. We propose a novel, paradigm shifting hypothesis that this frequently deleted locus is also associated with a cluster of microRNA genes- miR-3622a/b- that are lost in PCa and play an important mechanistic role in progression and metastasis. In this study, we demonstrate the role of miR-3622b in prostate cancer. Expression analyses in a cohort of PCa clinical specimens and cell lines show that miR-3622b expression is frequently lost in prostate cancer. Low miR-3622b expression was found to be associated with tumor progression and poor biochemical recurrence-free survival. Further, our analyses suggest that miR-3622b expression is a promising prostate cancer diagnostic biomarker that exhibits 100% specificity and 66% sensitivity. Restoration of miR-3622b expression in PCa cell lines led to reduced cellular viability, proliferation, invasiveness, migration and increased apoptosis. miR-3622b overexpression in vivo induced regression of established prostate tumor xenografts pointing to its therapeutic potential. Further, we found that miR-3622b directly represses Epidermal Growth Factor Receptor (EGFR). In conclusion, our study suggests that miR-3622b plays a tumor suppressive role and is frequently downregulated in prostate cancer, leading to EGFR upregulation. Importantly, miR-3622b has associated diagnostic, prognostic and therapeutic potential. Considering the association of chr8p21 loss with poor prognosis, our findings are highly significant and support a novel concept that associates a long standing observation of frequent loss of a chromosomal region with a novel miRNA in prostate cancer.

AB - Genomic loss of chromosome (chr) 8p21 region, containing prostate-specific NKX3.1 gene, is a frequent alteration of the prostate cancer (PCa) oncogenome. We propose a novel, paradigm shifting hypothesis that this frequently deleted locus is also associated with a cluster of microRNA genes- miR-3622a/b- that are lost in PCa and play an important mechanistic role in progression and metastasis. In this study, we demonstrate the role of miR-3622b in prostate cancer. Expression analyses in a cohort of PCa clinical specimens and cell lines show that miR-3622b expression is frequently lost in prostate cancer. Low miR-3622b expression was found to be associated with tumor progression and poor biochemical recurrence-free survival. Further, our analyses suggest that miR-3622b expression is a promising prostate cancer diagnostic biomarker that exhibits 100% specificity and 66% sensitivity. Restoration of miR-3622b expression in PCa cell lines led to reduced cellular viability, proliferation, invasiveness, migration and increased apoptosis. miR-3622b overexpression in vivo induced regression of established prostate tumor xenografts pointing to its therapeutic potential. Further, we found that miR-3622b directly represses Epidermal Growth Factor Receptor (EGFR). In conclusion, our study suggests that miR-3622b plays a tumor suppressive role and is frequently downregulated in prostate cancer, leading to EGFR upregulation. Importantly, miR-3622b has associated diagnostic, prognostic and therapeutic potential. Considering the association of chr8p21 loss with poor prognosis, our findings are highly significant and support a novel concept that associates a long standing observation of frequent loss of a chromosomal region with a novel miRNA in prostate cancer.

KW - Chr8p21

KW - EGFR

KW - MiR-3622b

KW - Prostate cancer

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=84994205124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994205124&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.11865

DO - 10.18632/oncotarget.11865

M3 - Article

C2 - 27611943

AN - SCOPUS:84994205124

VL - 7

SP - 70388

EP - 70403

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 43

ER -